1696 related articles for article (PubMed ID: 8923860)
1. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
2. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
3. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome.
Grinspoon S; Corcoran C; Rosenthal D; Stanley T; Parlman K; Costello M; Treat M; Davis S; Burrows B; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1999 Jan; 84(1):201-6. PubMed ID: 9920084
[TBL] [Abstract][Full Text] [Related]
5. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
6. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
7. Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting.
Huang JS; Wilkie SJ; Sullivan MP; Grinspoon S
J Clin Endocrinol Metab; 2001 Aug; 86(8):3533-9. PubMed ID: 11502775
[TBL] [Abstract][Full Text] [Related]
8. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
[TBL] [Abstract][Full Text] [Related]
9. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
[TBL] [Abstract][Full Text] [Related]
10. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.
Grinspoon S; Corcoran C; Stanley T; Baaj A; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 2000 Jan; 85(1):60-5. PubMed ID: 10634364
[TBL] [Abstract][Full Text] [Related]
11. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
[TBL] [Abstract][Full Text] [Related]
12. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
13. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
14. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
15. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
[TBL] [Abstract][Full Text] [Related]
18. Serum hormones in men with human immunodeficiency virus-associated wasting.
Dobs AS; Few WL; Blackman MR; Harman SM; Hoover DR; Graham NM
J Clin Endocrinol Metab; 1996 Nov; 81(11):4108-12. PubMed ID: 8923868
[TBL] [Abstract][Full Text] [Related]
19. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity.
Mauras N; Hayes V; Welch S; Rini A; Helgeson K; Dokler M; Veldhuis JD; Urban RJ
J Clin Endocrinol Metab; 1998 Jun; 83(6):1886-92. PubMed ID: 9626114
[TBL] [Abstract][Full Text] [Related]
20. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
